Compare DuPont de Nemours Inc (DD) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DuPont de Nemours Inc vs DENTSPLY SIRONA Inc — how do they compare? DuPont de Nemours Inc trades at $144.5 (market cap $19.51B), while DENTSPLY SIRONA Inc trades at $11.38 (market cap $2.31B). The key difference: DuPont de Nemours Inc is far larger — about 8.4× DENTSPLY SIRONA Inc's market cap, and DENTSPLY SIRONA Inc pays the higher dividend (5.04%). Which is the better fit depends on your goals.
| DD | XRAY | |
|---|---|---|
Market Cap | $19.51B | $2.31B |
Sector | Basic Materials | Health |
52-Week High | $154.59 | $14.68 |
52-Week Low | $90.24 | $9.64 |
Enterprise Value | $20.90B | $4.39B |
Dividend Yield | 1.66% | 5.04% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DuPont (DD) trades at $143.64, up 1.47% today, with strong technical momentum as price approaches resistance near $146. The company reported three consecutive quarterly earnings beats, with Q2 2026 EPS of $1.88 exceeding the $1.76 estimate, and raised full-year 2026 guidance. Recent news highlights contract wins in water treatment and R&D innovation awards, though the stock faces valuation concerns with a P/E of 62 and negative net income in 2025.
The outlook is cautiously optimistic given earnings momentum and analyst bullishness (58% buy ratings), but high valuation and thin profit margins pose risks. The consensus price target of $232.80 suggests significant upside if execution continues, though investors should monitor debt levels and PFAS litigation developments that could impact financials.
DENTSPLY SIRONA (XRAY) trades at $11.40, down 2.23% amid ongoing revenue declines and negative profitability. The stock shows bearish technical signals with support at $11 and resistance at $12. Recent Q2 2026 earnings beat expectations with $0.52 EPS but revenue fell 4.1% year-over-year to $898 million, reflecting persistent challenges in dental markets. The company maintains a 'Hold' analyst consensus with a $11.50 price target while executing its turnaround strategy.
Investment outlook remains cautious given six consecutive quarters of revenue declines and negative net margins. The company's restructuring efforts and new CFO appointment offer potential for operational improvement, but weak European demand and competitive pressures pose significant headwinds. With debt-to-asset ratio rising to 42.88% in 2025, financial leverage adds risk to the recovery thesis.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DuPont de Nemours Inc
DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the electronics and communication, automotive, construction, safety and protection, and water management industries. DuPont benefits from the ability to produce patented specialty chemicals that command pricing power. Noteworthy products include Kevlar, Tyvek, and Nomex have evolved over time to enable a wide range of applications across multiple industries.
Read more on DD →About DENTSPLY SIRONA Inc
Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →
